Extremity Findings of Methotrexate Embryopathy.

Hand (N Y)

Children's National Health System, Washington, DC, USA.

Published: January 2020

Methotrexate (MTX) is widely used as an immunosuppressant, chemotherapeutic, and abortifacient agent. It is also a potent teratogen, and intentional or unintentional exposure during pregnancy is associated with heterogeneous birth anomalies. We retrospectively reviewed a cohort of patients who presented to our clinic with limb anomalies in the setting of MTX embryopathy. In our case series, we describe 7 cases of patients who had limb anomalies with heterogeneous functionality, from severely debilitating to completely asymptomatic. Most of the upper extremity anomalies in our group were managed conservatively. Methotrexate embryopathy is a rare but clinically important entity with phenotypic and functional variability. This series underscores the need for proper counseling of patients and raises concern regarding using this medication for the purpose of abortion.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6966302PMC
http://dx.doi.org/10.1177/1558944719837657DOI Listing

Publication Analysis

Top Keywords

methotrexate embryopathy
8
limb anomalies
8
extremity findings
4
findings methotrexate
4
embryopathy methotrexate
4
methotrexate mtx
4
mtx immunosuppressant
4
immunosuppressant chemotherapeutic
4
chemotherapeutic abortifacient
4
abortifacient agent
4

Similar Publications

Autoimmune rheumatic diseases (ARDs) often affect women during their reproductive years, and early studies of pregnancy in these patients reported high rates of adverse outcomes. Continuation or initiation of safe and effective medications in the preconception period is beneficial for maintaining or achieving disease quiescence throughout pregnancy thereby improving both maternal and pregnancy outcomes. The European Alliance of Associations for Rheumatology, the American College of Rheumatology, and the British Society for Rheumatology have published recommendations and guidelines regarding management of ARDs during pregnancy.

View Article and Find Full Text PDF
Article Synopsis
  • The AGA Institute Clinical Practice Update provides guidance on managing gastrointestinal and liver diseases in pregnant patients, incorporating both published evidence and expert opinions.
  • Key recommendations include preconception counseling for reproductive-aged individuals, individualized health interventions during pregnancy, and the coordination of care for high-risk cases involving complex conditions.
  • The guidelines emphasize that while Best Practice Advice statements are based on current literature, they do not have formal ratings for evidence quality, reflecting the need for case-specific assessment.
View Article and Find Full Text PDF

The incidence of ectopic pregnancy (EP) has increased in recent years, owing to causes such as pelvic inflammatory diseases and assisted reproductive technologies (ART). The present study reported a case of a 33-year-old nulliparous woman with a history of previous ectopic pregnancies, who underwent pelvic ultrasound in August 2022, which revealed a double EP including a cervical pregnancy and a tubal stump pregnancy. Despite known risk factors and elevated beta-human chorionic gonadotropin (β-hCG) levels, a conservative approach, utilizing multiple doses of systemic methotrexate (MTX) injections, was employed to preserve fertility at the Regional Perinatal Center in Aktobe, Kazakhstan.

View Article and Find Full Text PDF
Article Synopsis
  • Research on prenatal medication safety has mainly focused on mothers, with little attention to the effects of fathers' medication use during the time leading up to conception.
  • A study analyzed data from over 4 million pregnancies in the U.S. to identify the most common medications prescribed to fathers in the 90 days before conception.
  • Results indicated that over a third of fathers filled prescriptions, with categories like psychotropics and antibiotics being common, some of which are known to pose risks to fetal health, highlighting a need for more research on paternal medication effects.
View Article and Find Full Text PDF

Pyomyositis is a purulent infection of skeletal muscle that is mostly observed in tropical countries. Aseptic pyomyositis is a rare, potentially life-threatening disorder characterized by the formation of sterile pus in muscle. We present a case of 53-years old female, diagnosed case of seropositive rheumatoid arthritis, presented with pain and swelling of the right calf muscle for 2 weeks.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!